Why is cabergoline not sold in China?

Cabergoline, a dopamine receptor agonist, has important applications in the medical field, especially in endocrinology. This drug is mainly used to treat endocrine-related diseases such as hyperprolactinemia, postpartum mastitis, and acromegaly. By activating dopamine receptors, cabergoline can effectively inhibit the excessive secretion of prolactin and growth hormone, thereby helping patients relieve symptoms and improve their quality of life.

However, although cabergoline has shown significant efficacy in treating certain diseases, it is not commercially available in China. There are two main reasons behind this.

First, drug safety is an important factor in deciding whether to introduce new drugs. Although cabergoline is effective, it may also cause some potential side effects. Some patients may experience nausea, vomiting, dizziness and other uncomfortable symptoms after use, and even a few patients may face serious side effects such as heart valve fibrosis and liver function damage. These adverse reactions pose a certain threat to the patient's health. Therefore, the country has chosen not to sell and use this drug domestically to protect the patient's health.

Secondly, from the perspective of drug supervision, the country has implemented strict regulatory policies on the sale and use of drugs. All drugs sold domestically require strict approval by the national drug regulatory authorities. Unfortunately, cabergoline failed to pass the relevant domestic approval procedures and therefore could not obtain sales and use licenses. This is another important reason why cabergoline cannot be purchased in China.

In summary, although cabergoline has certain efficacy in the treatment of specific endocrine diseases, considering its potential side effects and failure to pass domestic drug approval, this drug has not been marketed in China. For patients who require such drug treatment, it is recommended to find other suitable alternative drugs or treatment options under the guidance of a doctor.